IPM researchers publish scientific and technical articles on a variety of topics from product development and clinical trial results to regulatory policy. Scroll through or use the Filtered Search in the left sidebar to locate articles by keyword, author, journal name or year published.
Review Articles and Commentary
Microbicides in the prevention of HIV infection.
Nuttall J. Drugs 70, no. 10 (June 2010): 1231-1243.
Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.
das Neves J., Amiji M.M., Bahia M.F., Sarmento B. Adv Drug Deliv Rev 62, no. 4-5 (2010): 458-477.
Ensuring that developing countries have access to new healthcare products: the role of product development partnerships.
Brooks A.D., Wells W.A., McLean T.D., Khanna R., Coghlan R., Mertenskoetter T., Privor-Dumm L.A., Krattiger A., Mahoney R.T. Innovation Strategy Today 3, no. 1(January 2010): 1-5.
Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese Rhesus macaques
Pal R., Nuttall J., Galmin L., Weiss D., Chung H-K., Romano J. Virology 386, no. 1 (2009): 102-8.
The future of HIV microbicides: challenges and opportunities
Garg A.B., Nuttall J., Romano J. Antiviral Chemistry & Chemotherapy 19, no. 4 (2009):143-50
Microbicide delivery: formulation technologies and strategies
Romano J., Malcolm R.K., Garg S., Rohan L.C., Kaptur P.E. Current Opinion HIV/AIDS 3 (2008): 558-66
Vaginal microbicides: What does the future hold?
Cates W., Rosenberg Z. Contemporary OB/GYN Supplement. April 15, 2008.
The future of HIV prevention: prospects for an effective anti-HIV microbicide
Nuttall J., Romano J., Douville K., Galbreath C., Nel A., Heyward W., Mitchnick M., Walker S., Rosenberg Z. Infectious Disease Clinics of North America 21 (2007): 219-39
Microbicides for the prevention of HIV infection in women: an overview of recent trials
Rosenberg Z., Nel A., Heyward W., Mitchnick M. Current Opinion HIV/AIDS 1, no. 6 (2006): 514-9.
Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Martinez J., Coplan P., Wainberg M.A. Antiviral Research 71, no. 2-3 (2006): 343-50